Navigation Links
Test to detect pre-menstrual syndrome
Date:12/21/2012

This press release is available in German.

Even though there are many women who do not notice any special symptoms, there are some whose pre-menstrual disorders hamper their everyday lives:depressive mood, anxiety, excessive emotional sensitivity, fatigue, lack of concentration, headache, etc. Nevertheless, according to Leire Aperribai, PhD holder in Psychology from the UPV/EHU-University of the Basque Country, unified criteria for defining and diagnosing this disease have yet to be agreed on, "and so it is difficult to develop suitable interventions to treat women suffering from these symptoms."

Aperribai has sought to fill this gap through her PhD thesis. Her first task was to define the disorder, and to do this she took as her basis the 4th version of the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association.

This manual defines premenstrual dysphoric disorder and proposes criteria for diagnosing it.For example, it explains that the symptoms are sufficiently serious to cause clear damage, socially as well as in the workplace, and points out that this takes place during the luteal phase, in other words, during the period between ovulation and menstruation.The manual also explains that the symptoms disappear at the onset of menstruation, and for it to be regarded as a disorder, it is necessary to display at least 5 symptoms related to it, and one of them has to be among the following:depressive mood, feelings of desperation or self-rejection; clear internal anxiety, tension, a feeling of not being able to take any more; clear emotional lability, in other words, sadness, bursting into tears or manifestations of emotional over-sensitiveness towards rejection by other people; and irascibility or irritability.

In Aperribai's view, the manual gives a special identity to premenstualdysphoric disorder, despite the fact that it is still classified among those described as "non-specific depressive disorders," so it constitutes a firm proposal as it takes the main groups of symptoms into consideration. Aperribai also added that among the current classifications, this is the one that has been most welcomed.

Reliable and useful

So, taking as the starting point the definitions and criteria provided by the manual, Aperribai has produced a set of questions and has validated them through interviews given by women who are either working or studying on any of the UPV/EHU'sthree campuses.And this way she has verified its reliability.In fact, and in accordance with current calculations, premenstrual dysphoricdisorder is suffered by between 3% and 10% of the population; in the study done by Aperribai, by contrast, it has been found to affect 15%.

The author has explained that this difference is "normal because it concerns test screening.In other words, this is not a diagnostic tool, but a filter to distinguishthose who suffer from the disorder fromthose who do not."In this respect, she has stressed its usefulness, both in the area of research and in health centres.It takes 10 minutes or less to do the test and a lot of progress can be made with it.After that, diagnostic tests are carried out in positive cases and these can take up to two months.

The title of the thesis is "An Evaluation of Premenstrual Dysphoric Disorder: building a screening tool" (UnaevaluacindelTrastornoDisfrico Premenstrual: construccin de unaherramienta de screening).The test is currently being translated into Basque:"We've done one part, but there is still quite a way to go," she says.
'/>"/>

Contact: Aitziber Lasa
a.lasa@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert  

Related medicine news :

1. Charge detector for ion chromatography co-developed by UT Arlington and Thermo Fisher Scientific
2. Targeted micro-bubbles detect artery inflammation, MU study finds
3. Prostate cancer now detectable by imaging-guided biopsy
4. Fruit Flies Use Detection System to Avoid Spoiled Food
5. Mayo Clinic: Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
6. Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
7. Math detects contamination in water distribution networks
8. New test may improve cervical cancer detection
9. Enhancing breast cancer detection
10. New statistical method offers automatic mitotic cell detection for cancer diagnosis
11. Simple ovarian cancer symptom survey that checks for 6 warning signs may improve early detection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Test to detect pre-menstrual syndrome
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
(Date:10/12/2017)... Miramar, FL (PRWEB) , ... October 12, 2017 ... ... is presenting the latest in wound care advancements to physician colleagues, skilled nursing ... lecture is titled, "Navigating the Treacherous Waters of Wound Care." , "At many ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:10/2/2017)... Oct. 2, 2017  AllianceRx Walgreens Prime, the combined ... Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), ... which included the unveiling of new signage at its ... well as at a few other company-owned facilities across ... to patients, some of whom will begin to see ...
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
Breaking Medicine Technology: